In an abstract for the 2016 San Antonio Breast Cancer Symposium in December, Puma said it was using the anti-diarrheal medicine loperamide for ...
News
- Puma Biotech Crashes After Diarrhea Risk is Linked to Breast Cancer Drug
- Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity
Puma Biotechnology Inc (NYSE:PBYI) just announced its abstract for an upcoming 2016 San Antonio Breast Cancer Symposium (SABCS), which will ...
- Cholesterol drug shows promise to help reverse heart disease
The new ones are biotech drugs that are expensive to make — Repatha costs $14,000 a year and insurers often won't pay. They must be given as ...
- Active biotech company shares in the news: Immunomedics Inc. (NASDAQ:IMMU), Trevena, Inc ...
... presentation at the 2016 San Antonio Breast Cancer Symposium (SABCS) to be held at the Henry B. Gonzalez Convention Center in San Antonio, ...
- Sizzling Stock Alert - Puma Biotechnology, (NYSE:PBYI), Zimmer Biomet Holdings, (NYSE:ZBH)
Puma Biotechnology Inc (NYSE:PBYI) traded 6,932,205 shares on last ... Symposium (SABCS), December 6 – 10, 2016, in San Antonio, Texas.